Literature DB >> 28509066

Cyclophosphamide induced early-onset interstitial lung disease.

Abdullah Ozkok1, Sema Kaymaz2, Omer Celal Elcioglu2, Ali Bakan2, Ali Riza Odabas2.   

Abstract

Entities:  

Keywords:  Cyclophosphamide; Interstitial lung disease; Lung fibrosis

Year:  2012        PMID： 28509066      PMCID： PMC5411529          DOI： 10.1007/s13730-012-0021-6

Source DB:  PubMed          Journal:  CEN Case Rep        ISSN： 2192-4449


× No keyword cloud information.
  4 in total

1.  [A case of nephrotic syndrome associated with severe interstitial pneumonitis due to cyclophosphamide whose life was saved by steroid pulse therapy].

Authors:  H Yamada; T Fujimoto; Y Ishii; S Matsuda
Journal:  Nihon Jinzo Gakkai Shi       Date:  1995-09

2.  Pulmonary fibrosis induced by cyclophosphamide.

Authors:  A Segura; A Yuste; A Cercos; P López-Tendero; R Gironés; J A Pérez-Fidalgo; C Herranz
Journal:  Ann Pharmacother       Date:  2001 Jul-Aug       Impact factor: 3.154

Review 3.  Cyclophosphamide-induced late-onset lung disease.

Authors:  Kunio Hamada; Sonoko Nagai; Masanori Kitaichi; Guang Jin; Michio Shigematsu; Taishi Nagao; Atsuyasu Sato; Michiaki Mishima
Journal:  Intern Med       Date:  2003-01       Impact factor: 1.271

4.  Interstitial pneumonitis probably induced by cyclophosphamide in nephrosis.

Authors:  H Harigaya; K Matsubara; H Nigami; K Baba
Journal:  Acta Paediatr Jpn       Date:  1997-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.